Skip to main content
main-content

Zeitschrift

Cardiovascular Diabetology

Cardiovascular Diabetology 1/2017

Ausgabe 1/2017

Inhaltsverzeichnis ( 160 Artikel )

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Improved trends in cardiovascular complications among subjects with type 2 diabetes in Korea: a nationwide study (2006–2013)

Chang Hee Jung, Jin Ook Chung, Kyungdo Han, Seung-Hyun Ko, Kyung Soo Ko, Joong-Yeol Park, on Behalf of the Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome

Antonino Tuttolomondo, Alessandra Casuccio, Giovanni Guercio, Carlo Maida, Alessandro Del Cuore, Domenico Di Raimondo, Irene Simonetta, Danilo Di Bona, Rosaria Pecoraro, Vittoriano Della Corte, Eliana Gulotta, Gaspare Gulotta, Antonio Pinto

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Blood pressure control in type 2 diabetic patients

Alon Grossman, Ehud Grossman

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy

Yoo-Ri Chung, Sung Wook Park, Shin-Young Choi, Seung Woo Kim, Ka Young Moon, Jeong Hun Kim, Kihwang Lee

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Leptin and adiponectin as predictors of cardiovascular risk after gestational diabetes mellitus

Tove Lekva, Annika Elisabet Michelsen, Pål Aukrust, Tore Henriksen, Jens Bollerslev, Thor Ueland

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Differential effects of glucagon-like peptide-1 receptor agonists on heart rate

Martin Lorenz, Francesca Lawson, David Owens, Denis Raccah, Christine Roy-Duval, Anne Lehmann, Riccardo Perfetti, Lawrence Blonde

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Diabetes does not impact the diagnostic performance of contrast-based fractional flow reserve: insights from the CONTRAST study

Giuseppe Gargiulo, Eugenio Stabile, Marco Ferrone, Emanuele Barbato, Frederik M. Zimmermann, Julien Adjedj, Barry Hennigan, Mitsuaki Matsumura, Nils P. Johnson, William F. Fearon, Allen Jeremias, Bruno Trimarco, Giovanni Esposito, On behalf of the CONTRST Study Investigators

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin

Toshiyuki Hayashi, Tomoyasu Fukui, Noriko Nakanishi, Saki Yamamoto, Masako Tomoyasu, Anna Osamura, Makoto Ohara, Takeshi Yamamoto, Yasuki Ito, Tsutomu Hirano

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes

Javad Habibi, Annayya R. Aroor, James R. Sowers, Guanghong Jia, Melvin R. Hayden, Mona Garro, Brady Barron, Eric Mayoux, R. Scott Rector, Adam Whaley-Connell, Vincent G. DeMarco

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathways

Jason Kar Sheng Lew, James T. Pearson, Daryl O. Schwenke, Rajesh Katare

01.12.2017 | Review | Ausgabe 1/2017 Open Access

The association between diabetes and dermal microvascular dysfunction non-invasively assessed by laser Doppler with local thermal hyperemia: a systematic review with meta-analysis

Dagmar Fuchs, Pepijn P. Dupon, Laura A. Schaap, Richard Draijer

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

T-cadherin deficiency increases vascular vulnerability in T2DM through impaired NO bioactivity

Han Wang, Ling Tao, Anastasia Ambrosio, Wenjun Yan, Ross Summer, Wayne Bond Lau, Yajing Wang, Xinliang Ma

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes

Thomas Jax, Alin Stirban, Arne Terjung, Habib Esmaeili, Andreas Berk, Sandra Thiemann, Robert Chilton, Maximilian von Eynatten, Nikolaus Marx

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Obesity, metabolic syndrome and cardiovascular prognosis: from the Partners coronary computed tomography angiography registry

Edward A. Hulten, Marcio Sommer Bittencourt, Ryan Preston, Avinainder Singh, Carla Romagnolli, Brian Ghoshhajra, Ravi Shah, Siddique Abbasi, Suhny Abbara, Khurram Nasir, Michael Blaha, Udo Hoffmann, Marcelo F. Di Carli, Ron Blankstein

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Skin autofluorescence is associated with inappropriate left ventricular mass and diastolic dysfunction in subjects at risk for cardiovascular disease

Chun-Cheng Wang, Yao-Chang Wang, Guei-Jane Wang, Ming-Yi Shen, Yen-Lin Chang, Show-Yih Liou, Hung-Chih Chen, An-Sheng Lee, Kuan-Cheng Chang, Wei-Yu Chen, Chiz-Tzung Chang

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

The renal tubular damage marker urinary N-acetyl-β-d-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes

So Ra Kim, Yong-ho Lee, Sang-Guk Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study

Christian Herder, Julia M. Kannenberg, Maren Carstensen-Kirberg, Cornelia Huth, Christa Meisinger, Wolfgang Koenig, Annette Peters, Wolfgang Rathmann, Michael Roden, Barbara Thorand

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes

James Xu, Rohan Rajaratnam

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Inhibition of dynamin-related protein 1 protects against myocardial ischemia–reperfusion injury in diabetic mice

Mingge Ding, Qianqian Dong, Zhenghua Liu, Zheng Liu, Yinxian Qu, Xing Li, Cong Huo, Xin Jia, Feng Fu, Xiaoming Wang

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation

Kazuo Furukawa, Ichiro Fuse, Yuriko Iwakura, Hidekazu Sotoyama, Osamu Hanyu, Hiroyuki Nawa, Hirohito Sone, Nobuyuki Takei

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Obesity and type 2 diabetes have additive effects on left ventricular remodelling in normotensive patients-a cross sectional study

Kirstie A. De Jong, Juliane K. Czeczor, Smithamol Sithara, Kevin McEwen, Gary D. Lopaschuk, Alan Appelbe, Kimberly Cukier, Mark Kotowicz, Sean L. McGee

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes

Gian Paolo Fadini, Benedetta Maria Bonora, Mattia Albiero, Martina Zaninotto, Mario Plebani, Angelo Avogaro

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up

Marcus Wiemer, Sinisa Stoikovic, Alexander Samol, Zisis Dimitriadis, Juan M. Ruiz-Nodar, Ralf Birkemeyer, Jacques Monsegu, Gérard Finet, David Hildick-Smith, Damras Tresukosol, Enrique Garcia Novo, Jacques J. Koolen, Emanuele Barbato, Gian Battista Danzi, on behalf of NOBORI 2 investigators

01.12.2017 | Original article | Ausgabe 1/2017 Open Access

Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients

Aurélien Mary, Agnes Hartemann, Sophie Liabeuf, Carole Elodie Aubert, Salim Kemel, Joe Elie Salem, Philippe Cluzel, Aurélie Lenglet, Ziad A. Massy, Jean-Daniel Lalau, Romuald Mentaverri, Olivier Bourron, Saïd Kamel

01.12.2017 | Erratum | Ausgabe 1/2017 Open Access

Erratum to: Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway

Concepción Peiró, Tania Romacho, Verónica Azcutia, Laura Villalobos, Emilio Fernández, Juan P. Bolaños, Salvador Moncada, Carlos F. Sánchez-Ferrer

01.12.2017 | Original article | Ausgabe 1/2017 Open Access

A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation

Christian Ott, Agnes Jumar, Kristina Striepe, Stefanie Friedrich, Marina V. Karg, Peter Bramlage, Roland E. Schmieder

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes

Alessandra Dei Cas, Valentina Spigoni, Monia Cito, Raffaella Aldigeri, Valentina Ridolfi, Elisabetta Marchesi, Michela Marina, Eleonora Derlindati, Rosalia Aloe, Riccardo C. Bonadonna, Ivana Zavaroni

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Diagnostic approaches for diabetic cardiomyopathy

A. Lorenzo-Almorós, J. Tuñón, M. Orejas, M. Cortés, J. Egido, Ó. Lorenzo

01.12.2017 | Original article | Ausgabe 1/2017 Open Access

Effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysis

Michael Pfeifer, Raymond R. Townsend, Michael J. Davies, Ujjwala Vijapurkar, Jimmy Ren

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: The Rural Chinese Cohort Study

Ming Zhang, Bingyuan Wang, Yu Liu, Xizhuo Sun, Xinping Luo, Chongjian Wang, Linlin Li, Lu Zhang, Yongcheng Ren, Yang Zhao, Junmei Zhou, Chengyi Han, Jingzhi Zhao, Dongsheng Hu

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes

Zeqing Zhang, Xi Chen, Puhan Lu, Jianhua Zhang, Yongping Xu, Wentao He, Mengni Li, Shujun Zhang, Jing Jia, Shiying Shao, Junhui Xie, Yan Yang, Xuefeng Yu

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study

Ryotaro Bouchi, Masahiro Terashima, Yuriko Sasahara, Masahiro Asakawa, Tatsuya Fukuda, Takato Takeuchi, Yujiro Nakano, Masanori Murakami, Isao Minami, Hajime Izumiyama, Koshi Hashimoto, Takanobu Yoshimoto, Yoshihiro Ogawa

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction

Arpeeta Sharma, Luddwi Rizky, Nada Stefanovic, Mitchel Tate, Rebecca H. Ritchie, Keith W. Ward, Judy B. de Haan

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk

Katherine Kearney, Darren Tomlinson, Kerrie Smith, Ramzi Ajjan

01.12.2017 | Commentary | Ausgabe 1/2017 Open Access

Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group

Oliver Schnell, Eberhard Standl, Doina Catrinoiu, Stefano Genovese, Nebojsa Lalic, Jan Skra, Paul Valensi, Dario Rahelic, Antonio Ceriello

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Subclinical left ventricular diastolic dysfunction and incident type 2 diabetes risk: the Korean Genome and Epidemiology Study

Juri Park, Jin-Seok Kim, Seong Hwan Kim, Sunwon Kim, Sang Yup Lim, Hong-Euy Lim, Goo-Yeong Cho, Ki-Chul Sung, Jang-Young Kim, Inkyung Baik, Kwang Kon Koh, Jung Bok Lee, Seung Ku Lee, Chol Shin

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Clinical outcomes and glycaemic responses to different aerobic exercise training intensities in type II diabetes: a systematic review and meta-analysis

Aimee Grace, Erick Chan, Francesco Giallauria, Petra L. Graham, Neil A. Smart

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Lipoprotein(a) and incident type-2 diabetes: results from the prospective Bruneck study and a meta-analysis of published literature

Ellie Paige, Katya L. Masconi, Sotirios Tsimikas, Florian Kronenberg, Peter Santer, Siegfried Weger, Johann Willeit, Stefan Kiechl, Peter Willeit

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Association between obstructive sleep apnea severity and endothelial dysfunction in patients with type 2 diabetes

Vanessa Bironneau, François Goupil, Pierre Henri Ducluzeau, Marc Le Vaillant, Pierre Abraham, Samir Henni, Séverine Dubois, Audrey Paris, Pascaline Priou, Nicole Meslier, Claire Sanguin, Wojciech Trzépizur, Ramaroson Andriantsitohaina, Maria Carmen Martinez, Frédéric Gagnadoux

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Efficacy and safety of canagliflozin in patients with type 2 diabetes based on history of cardiovascular disease or cardiovascular risk factors: a post hoc analysis of pooled data

Michael J. Davies, Katherine Merton, Ujjwala Vijapurkar, Jacqueline Yee, Rong Qiu

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Impact of diabetes on outcome in critical limb ischemia with tissue loss: a large-scaled routine data analysis

Eva Freisinger, Nasser M. Malyar, Holger Reinecke, Holger Lawall

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial

Gian Paolo Fadini, Benedetta Maria Bonora, Giancarlo Zatti, Nicola Vitturi, Elisabetta Iori, Maria Cristina Marescotti, Mattia Albiero, Angelo Avogaro

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Glycemia and the cardioprotective effects of insulin pre-conditioning in the isolated rat heart

Yosuke Nakadate, Hiroaki Sato, Takeshi Oguchi, Tamaki Sato, Akiko Kawakami, Tadahiko Ishiyama, Takashi Matsukawa, Thomas Schricker

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes

N. González, Z. Moreno-Villegas, A. González-Bris, J. Egido, Ó. Lorenzo

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Pregnancy-associated plasma protein-A is a stronger predictor for adverse cardiovascular outcomes after acute coronary syndrome in type-2 diabetes mellitus

Wei-Ping Li, Moni B. Neradilek, Fu-Sheng Gu, Daniel A. Isquith, Zhi-Jun Sun, Xing Wu, Hong-Wei Li, Xue-Qiao Zhao

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Human serum RNase-L level is inversely associated with metabolic syndrome and age

Yi-Ting Wang, Ping-Huei Tseng, Chi-Ling Chen, Der-Sheng Han, Yu-Chiao Chi, Fen-Yu Tseng, Wei-Shiung Yang

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Metformin and sulodexide restore cardiac microvascular perfusion capacity in diet-induced obese rats

Judith van Haare, M. Eline Kooi, Jurgen W. G. E. van Teeffelen, Hans Vink, Jos Slenter, Hanneke Cobelens, Gustav J. Strijkers, Dennis Koehn, Mark J. Post, Marc van Bilsen

01.12.2017 | Study protocol | Ausgabe 1/2017 Open Access

Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial

Atsushi Tanaka, Michio Shimabukuro, Yosuke Okada, Isao Taguchi, Minako Yamaoka-Tojo, Hirofumi Tomiyama, Hiroki Teragawa, Seigo Sugiyama, Hisako Yoshida, Yasunori Sato, Atsushi Kawaguchi, Yumi Ikehara, Noritaka Machii, Tatsuya Maruhashi, Kosuke R. Shima, Toshinari Takamura, Yasushi Matsuzawa, Kazuo Kimura, Masashi Sakuma, Jun-ichi Oyama, Teruo Inoue, Yukihito Higashi, Shinichiro Ueda, Koichi Node, On Behalf of the EMBLEM Trial Investigators

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Subclinical inflammation associated with prolonged TIMP-1 upregulation and arterial stiffness after gestational diabetes mellitus: a hospital-based cohort study

Tiina Vilmi-Kerälä, Anneli Lauhio, Taina Tervahartiala, Outi Palomäki, Jukka Uotila, Timo Sorsa, Ari Palomäki

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes

Malgorzata Poreba, Magdalena Mostowik, Aleksander Siniarski, Renata Golebiowska-Wiatrak, Krzysztof Piotr Malinowski, Maciej Haberka, Ewa Konduracka, Jadwiga Nessler, Anetta Undas, Grzegorz Gajos

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Is ischemia the only factor predicting cardiovascular outcomes in all diabetes mellitus patients?

Mark W. Kennedy, Enrico Fabris, Harry Suryapranata, Elvin Kedhi

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells

Xiaomei Ren, Liqun Ren, Qin Wei, Hua Shao, Long Chen, Naifeng Liu

01.12.2017 | Erratum | Ausgabe 1/2017 Open Access

Erratum to: Obesity and type 2 diabetes have additive effects on left ventricular remodelling in normotensive patients-a cross sectional study

Kirstie A. De Jong, Juliane K. Czeczor, Smithamol Sithara, Kevin McEwen, Gary D. Lopaschuk, Alan Appelbe, Kimberly Cukier, Mark Kotowicz, Sean L. McGee

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Anatomic fat depots and cardiovascular risk: a focus on the leg fat using nationwide surveys (KNHANES 2008–2011)

Eugene Han, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, In-Kyu Lee, Bong-Soo Cha

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study

S. A. Peeters, L. Engelen, J. Buijs, A. Jorsal, H.-H. Parving, L. Tarnow, P. Rossing, C. G. Schalkwijk, C. D. A. Stehouwer

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Retinal vessel diameters and reactivity in diabetes mellitus and/or cardiovascular disease

R. Heitmar, G. Y. H. Lip, R. E. Ryder, A. D. Blann

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Remote ischemic preconditioning differentially attenuates post-ischemic cardiac arrhythmia in streptozotocin-induced diabetic versus nondiabetic rats

Zhaoyang Hu, Mou Chen, Ping Zhang, Jin Liu, Geoffrey W. Abbott

01.12.2017 | Erratum | Ausgabe 1/2017 Open Access

Erratum to: Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function

Chang-Chiang Chen, Hendra Susanto, Wen-Han Chuang, Ta-Yu Liu, Arivajiagane Arundhathi, Chih-Hong Wang

01.12.2017 | Erratum | Ausgabe 1/2017 Open Access

Erratum to: Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up

Marcus Wiemer, Sinisa Stojkovic, Alexander Samol, Zisis Dimitriadis, Juan M. Ruiz-Nodar, Ralf Birkemeyer, Jacques Monsegu, Gérard Finet, David Hildick-Smith, Damras Tresukosol, Enrique Garcia Novo, Jacques J. Koolen, Emanuele Barbato, Gian Battista Danzi, on behalf of NOBORI 2 investigators

01.12.2017 | Erratum | Ausgabe 1/2017 Open Access

Erratum to: Inhibition of dynamin-related protein 1 protects against myocardial ischemia–reperfusion injury in diabetic mice

Mingge Ding, Qianqian Dong, Zhenhua Liu, Zheng Liu, Yinxian Qu, Xing Li, Cong Huo, Xin Jia, Feng Fu, Xiaoming Wang

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice

Annayya R. Aroor, Javad Habibi, Hemanth Kumar Kandikattu, Mona Garro-Kacher, Brady Barron, Dongqing Chen, Melvin R. Hayden, Adam Whaley-Connell, Shawn B. Bender, Thomas Klein, Jaume Padilla, James R. Sowers, Bysani Chandrasekar, Vincent G. DeMarco

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Lipopolysaccharide-binding protein is associated with arterial stiffness in patients with type 2 diabetes: a cross-sectional study

Takeshi Sakura, Tomoaki Morioka, Atsushi Shioi, Yoshinori Kakutani, Yuya Miki, Yuko Yamazaki, Koka Motoyama, Katsuhito Mori, Shinya Fukumoto, Tetsuo Shoji, Masanori Emoto, Masaaki Inaba

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study

Hirotsugu Yamada, Atsushi Tanaka, Kenya Kusunose, Rie Amano, Munehide Matsuhisa, Hiroyuki Daida, Masaaki Ito, Hiroyuki Tsutsui, Mamoru Nanasato, Haruo Kamiya, Yasuko K. Bando, Masato Odawara, Hisako Yoshida, Toyoaki Murohara, Masataka Sata, Koichi Node, for the PROLOGUE Study Investigators

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Target organ damage and incident type 2 diabetes mellitus: the Strong Heart Study

Giovanni de Simone, Wenyu Wang, Lyle G. Best, Fawn Yeh, Raffaele Izzo, Costantino Mancusi, Mary J. Roman, Elisa T. Lee, Barbara V. Howard, Richard B. Devereux

01.12.2017 | Review | Ausgabe 1/2017 Open Access

SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease

Honghong Zou, Baoqin Zhou, Gaosi Xu

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL

Markolf Hanefeld, Louise Traylor, Ling Gao, Wolfgang Landgraf

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine

Weena J. Y. Chen, Michaela Diamant, Karin de Boer, Hendrik J. Harms, Lourens F. H. J. Robbers, Albert C. van Rossum, Mark H. H. Kramer, Adriaan A. Lammertsma, Paul Knaapen

01.12.2017 | Study protocol | Ausgabe 1/2017 Open Access

PRotective Effect on the coronary microcirculation of patients with DIabetes by Clopidogrel or Ticagrelor (PREDICT): study rationale and design. A randomized multicenter clinical trial using intracoronary multimodal physiology

Enrico Cerrato, Alicia Quirós, Mauro Echavarría-Pinto, Hernan Mejia-Renteria, Andres Aldazabal, Nicola Ryan, Nieves Gonzalo, Pilar Jimenez-Quevedo, Luis Nombela-Franco, Pablo Salinas, Iván J. Núñez-Gil, José Ramón Rumoroso, Antonio Fernández-Ortiz, Carlos Macaya, Javier Escaned

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

The addition of vildagliptin to metformin prevents the elevation of interleukin 1ß in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study

Arwa Younis, Dana Eskenazi, Ronen Goldkorn, Jonathan Leor, Nili Naftali-Shani, Enrique Z. Fisman, Alexander Tenenbaum, Ilan Goldenberg, Robert Klempfner

01.12.2017 | Study protocol | Ausgabe 1/2017 Open Access

Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk

Dirk Müller-Wieland, Lawrence A. Leiter, Bertrand Cariou, Alexia Letierce, Helen M. Colhoun, Stefano Del Prato, Robert R. Henry, Francisco J. Tinahones, Lisa Aurand, Jaman Maroni, Kausik K. Ray, Maja Bujas-Bobanovic

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Platelets, diabetes and myocardial ischemia/reperfusion injury

Isabella Russo, Claudia Penna, Tiziana Musso, Jasmin Popara, Giuseppe Alloatti, Franco Cavalot, Pasquale Pagliaro

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction

Jing-Wei Li, Yun-Dai Chen, Wei-Ren Chen, Qi You, Bo Li, Hao Zhou, Ying Zhang, Tian-Wen Han

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes

Trevor J. Orchard, Bertrand Cariou, Margery A. Connelly, James D. Otvos, Shuyu Zhang, Caryl J. Antalis, Tibor Ivanyi, Byron J. Hoogwerf

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Impact of diabetes duration and degree of carotid artery stenosis on major adverse cardiovascular events: a single-center, retrospective, observational cohort study

Minsu Noh, Hyunwook Kwon, Chang Hee Jung, Sun U. Kwon, Min Seon Kim, Woo Je Lee, Joong Yeol Park, Youngjin Han, Hyangkyoung Kim, Tae-Won Kwon, Yong-Pil Cho

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes

Celestino Sardu, Michelangela Barbieri, Matteo Santamaria, Valerio Giordano, Cosimo Sacra, Pasquale Paolisso, Alessandro Spirito, Raffaele Marfella, Giuseppe Paolisso, Maria Rosaria Rizzo

01.12.2017 | Review | Ausgabe 1/2017 Open Access

The regulatory role of DPP4 in atherosclerotic disease

Lihua Duan, Xiaoquan Rao, Chang Xia, Sanjay Rajagopalan, Jixin Zhong

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus

Xingxing He, Xiang Hu, Xiaojing Ma, Hang Su, Lingwen Ying, Jiahui Peng, Xiaoping Pan, Yuqian Bao, Jian Zhou, Weiping Jia

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Impact of glycemic control on aortic stiffness, left ventricular mass and diastolic longitudinal function in type 2 diabetes mellitus

Michaela Kozakova, Carmela Morizzo, Alan G. Fraser, Carlo Palombo

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Sex difference in the risk for exercise-induced albuminuria correlates with hemoglobin A1C and abnormal exercise ECG test findings

Rafael Y. Brzezinski, Inbal Etz-Hadar, Ayelet Grupper, Michal Ehrenwald, Itzhak Shapira, David Zeltser, Shlomo Berliner, Ori Rogowski, Roy Eldor, Shani Shenhar-Tsarfaty

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

In vivo administration of urolithin A and B prevents the occurrence of cardiac dysfunction in streptozotocin-induced diabetic rats

Monia Savi, Leonardo Bocchi, Pedro Mena, Margherita Dall’Asta, Alan Crozier, Furio Brighenti, Donatella Stilli, Daniele Del Rio

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Red blood cell distribution width as a prognostic marker in patients with heart failure and diabetes mellitus

Andrew Xanthopoulos, Gregory Giamouzis, Andreas Melidonis, Takeshi Kitai, Efi Paraskevopoulou, Pinelopi Paraskevopoulou, Sotirios Patsilinakos, Filippos Triposkiadis, John Skoularigis

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Diabetic retinopathy is associated with diastolic dysfunction in type 2 diabetic patients with non-ischemic dilated cardiomyopathy

Yoo-Ri Chung, Se-Jun Park, Ka Young Moon, Seoyoung Annie Choi, Hong-Seok Lim, Sung Wook Park, Jeong Hun Kim, Kihwang Lee

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Westernization of lifestyle affects quantitative and qualitative changes in adiponectin

Mitsunobu Kubota, Masayasu Yoneda, Norikazu Maeda, Haruya Ohno, Kenji Oki, Tohru Funahashi, Iichiro Shimomura, Noboru Hattori

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study

Fumika Shigiyama, Naoki Kumashiro, Masahiko Miyagi, Kayoko Ikehara, Eiichiro Kanda, Hiroshi Uchino, Takahisa Hirose

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Reduced HDL function in children and young adults with type 1 diabetes

Martin Heier, Mark S. Borja, Cathrine Brunborg, Ingebjørg Seljeflot, Hanna Dis Margeirsdottir, Kristian F. Hanssen, Knut Dahl-Jørgensen, Michael N. Oda

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study

Michio Shimabukuro, Atsushi Tanaka, Masataka Sata, Kazuoki Dai, Yoshisato Shibata, Yohei Inoue, Hiroki Ikenaga, Shinji Kishimoto, Kozue Ogasawara, Akira Takashima, Toshiyuki Niki, Osamu Arasaki, Koichi Oshiro, Yutaka Mori, Masaharu Ishihara, Koichi Node, on behalf of the Collaborators on the Effect of Miglitol on Glucose Metabolism in Acute Coronary Syndrome (MACS) Study

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Joint analysis of left ventricular expression and circulating plasma levels of Omentin after myocardial ischemia

Louis A. Saddic, Sarah M. Nicoloro, Olga T. Gupta, Michael P. Czech, Joshua Gorham, Stanton K. Shernan, Christine E. Seidman, Jon G. Seidman, Sary F. Aranki, Simon C. Body, Timothy P. Fitzgibbons, Jochen D. Muehlschlegel

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria

Emilie H. Zobel, Bernt Johan von Scholten, Henrik Reinhard, Frederik Persson, Tom Teerlink, Tine W. Hansen, Hans-Henrik Parving, Peter K. Jacobsen, Peter Rossing

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction

Mei-Tzu Wang, Sheng-Che Lin, Pei-Ling Tang, Wang-Ting Hung, Chin-Chang Cheng, Jin-Shiou Yang, Hong-Tai Chang, Chun-Peng Liu, Guang-Yuan Mar, Wei-Chun Huang

01.12.2017 | Erratum | Ausgabe 1/2017 Open Access

Erratum to: Impact of metabolic syndrome and its components on heart rate variability during hemodialysis: a cross-sectional study

Yu-Ming Chang, Chih-Chung Shiao, Ya-Ting Huang, I-Ling Chen, Chuan-Lan Yang, Show-Chin Leu, Hung-Li Su, Jsun-Liang Kao, Shih-Ching Tsai, Rong-Na Jhen, Ching-Cherng Uen, On behalf of SMCKD (Saint Mary’s hospital Chronic Kidney Disease) study group

01.12.2017 | Commentary | Ausgabe 1/2017 Open Access

Mirroring the CANTOS revolution: is anti-inflammatory therapy for diabetes just around the corner?

Alexander Tenenbaum, Enrique Z. Fisman

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Circulating sortilin level as a potential biomarker for coronary atherosclerosis and diabetes mellitus

Tae Jung Oh, Chang Ho Ahn, Bo-Rahm Kim, Kyoung Min Kim, Jae Hoon Moon, Soo Lim, Kyong Soo Park, Cheong Lim, HakChul Jang, Sung Hee Choi

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis

Santosh Gautam, Abiy Agiro, John Barron, Thomas Power, Harry Weisman, Jeff White

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes

Marta Hernández, Carolina López, Jordi Real, Joan Valls, Emilio Ortega-Martinez de Victoria, Federico Vázquez, Esther Rubinat, Minerva Granado-Casas, Nuria Alonso, Teresa Molí, Angels Betriu, Albert Lecube, Elvira Fernández, Richard David Leslie, Dídac Mauricio

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes

Kamel Mohammedi, Mark Woodward, Michel Marre, Stephen Colagiuri, Mark Cooper, Stephen Harrap, Giuseppe Mancia, Neil Poulter, Bryan Williams, Sophia Zoungas, John Chalmers

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Impact of CD14++CD16+ monocytes on plaque vulnerability in diabetic and non-diabetic patients with asymptomatic coronary artery disease: a cross-sectional study

Naofumi Yoshida, Hiroyuki Yamamoto, Toshiro Shinke, Hiromasa Otake, Masaru Kuroda, Daisuke Terashita, Hachidai Takahashi, Kazuhiko Sakaguchi, Yushi Hirota, Takuo Emoto, Hilman Zulkifli Amin, Taiji Mizoguchi, Tomohiro Hayashi, Naoto Sasaki, Tomoya Yamashita, Wataru Ogawa, Ken-ichi Hirata

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Hemoglobin A1c is associated with severity of coronary artery stenosis but not with long term clinical outcomes in diabetic and nondiabetic patients with acute myocardial infarction undergoing primary angioplasty

Jianqing She, Yangyang Deng, Yue Wu, Yulong Xia, Hongbing Li, Xiao Liang, Rui Shi, Zuyi Yuan

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Neutrophil gelatinase associated lipocalin (NGAL) is elevated in type 2 diabetics with carotid artery stenosis and reduced under metformin treatment

W. Eilenberg, S. Stojkovic, A. Piechota-Polanczyk, A. Kaider, N. Kozakowski, W. J. Weninger, J. Nanobachvili, J. Wojta, I. Huk, S. Demyanets, C. Neumayer

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects

Silvia Giovannini, Giovanni Tinelli, Federico Biscetti, Giuseppe Straface, Flavia Angelini, Dario Pitocco, Luciana Mucci, Raffaele Landolfi, Andrea Flex

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Gender differences in hospital admissions for major cardiovascular events and procedures in people with and without diabetes in England: a nationwide study 2004–2014

Anthony A. Laverty, Alex Bottle, Sung-Hee Kim, Bhakti Visani, Azeem Majeed, Christopher Millett, Eszter P. Vamos

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Selenoprotein S: a therapeutic target for diabetes and macroangiopathy?

Shan-shan Yu, Jian-ling Du

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure

Osnat Itzhaki Ben Zadok, Ran Kornowski, Ilan Goldenberg, Robert Klempfner, Yoel Toledano, Yitschak Biton, Enrique Z. Fisman, Alexander Tenenbaum, Gregory Golovchiner, Ehud Kadmon, Alexander Omelchenko, Tuvia Ben Gal, Alon Barsheshet

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Combined effect of metformin with ascorbic acid versus acetyl salicylic acid on diabetes-related cardiovascular complication; a 12-month single blind multicenter randomized control trial

Syed Wasif Gillani, Syed Azhar Syed Sulaiman, Mohi Iqbal Mohammad Abdul, Mirza R. Baig

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Changes in proteinuria and the risk of myocardial infarction in people with diabetes or pre-diabetes: a prospective cohort study

Anxin Wang, Yang Sun, Xiaoxue Liu, Zhaoping Su, Junjuan Li, Yanxia Luo, Shuohua Chen, Jianli Wang, Xia Li, Zhan Zhao, Huiping Zhu, Shouling Wu, Xiuhua Guo

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

New onset diabetes in adulthood is associated with a substantial risk for mortality at all ages: a population based historical cohort study with a decade-long follow-up

Inbar Zucker, Tamy Shohat, Rachel Dankner, Gabriel Chodick

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Contribution of serum FGF21 level to the identification of left ventricular systolic dysfunction and cardiac death

Yun Shen, Xueli Zhang, Xiaoping Pan, Yiting Xu, Qin Xiong, Zhigang Lu, Xiaojing Ma, Yuqian Bao, Weiping Jia

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study

Uchenna Anyanwagu, Jil Mamza, Richard Donnelly, Iskandar Idris

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults

Min Kyung Kim, Chul Woo Ahn, Shinae Kang, Ji Sun Nam, Kyung Rae Kim, Jong Suk Park

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Inverse associations between serum levels of secreted frizzled-related protein-5 (SFRP5) and multiple cardiometabolic risk factors: KORA F4 study

Maren Carstensen-Kirberg, Julia M. Kannenberg, Cornelia Huth, Christa Meisinger, Wolfgang Koenig, Margit Heier, Annette Peters, Wolfgang Rathmann, Michael Roden, Christian Herder, Barbara Thorand

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

The effect of exercise training on clinical outcomes in patients with the metabolic syndrome: a systematic review and meta-analysis

C. Ostman, N. A. Smart, D. Morcos, A. Duller, W. Ridley, D. Jewiss

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Association between carotid plaque characteristics and acute cerebral infarction determined by MRI in patients with type 2 diabetes mellitus

Beibei Sun, Xiao Li, Xiaosheng Liu, Xiaoqian Ge, Qing Lu, Xihai Zhao, Jun Pu, Jianrong Xu, Huilin Zhao

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus

Ira Gantz, Menghui Chen, Shailaja Suryawanshi, Catherine Ntabadde, Sukrut Shah, Edward A. O’Neill, Samuel S. Engel, Keith D. Kaufman, Eseng Lai

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin

Pia S. Pollack, Kristina D. Chadwick, David M. Smith, Martin Billger, Boaz Hirshberg, Nayyar Iqbal, David W. Boulton

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

The impact of cardiovascular co-morbidities and duration of diabetes on the association between microvascular function and glycaemic control

F. Casanova, D. D. Adingupu, F. Adams, K. M. Gooding, H. C. Looker, K. Aizawa, F. Dove, S. Elyas, J. J. F. Belch, P. E. Gates, R. C. Littleford, M. Gilchrist, H. M. Colhoun, A. C. Shore, F. Khan, W. D. Strain

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Evolution and bad prognostic value of advanced glycation end products after acute heart failure: relation with body composition

Beatriz Paradela-Dobarro, Ángel Fernández-Trasancos, Diana Bou-Teen, Sonia Eiras, Rocío González-Ferreiro, Rosa M. Agra, Alfonso Varela-Román, Ana I. Castro-Pais, Marcos C. Carreira, Felipe F. Casanueva, Ezequiel Álvarez, José R. González-Juanatey

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes

Ernesto Maddaloni, Yu Xia, Kyoungmin Park, Stephanie D’Eon, Liane J. Tinsley, Ronald St-Louis, Mogher Khamaisi, Qian Li, George L. King, Hillary A. Keenan

01.12.2017 | Erratum | Ausgabe 1/2017 Open Access

Erratum to: Changes in proteinuria and the risk of myocardial infarction in people with diabetes or pre-diabetes: a prospective cohort study

Anxin Wang, Yang Sun, Xiaoxue Liu, Zhaoping Su, Junjuan Li, Yanxia Luo, Shuohua Chen, Jianli Wang, Xia Li, Zhan Zhao, Huiping Zhu, Shouling Wu, Xiuhua Guo

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance

Alessandra Giannella, Claudia Maria Radu, Lorenzo Franco, Elena Campello, Paolo Simioni, Angelo Avogaro, Saula Vigili de Kreutzenberg, Giulio Ceolotto

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

NTproBNP in insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato Study

Stefano Baldassarre, Salvatore Fragapani, Antonio Panero, Debora Fedele, Silvia Pinach, Manuela Lucchiari, Anna Rita Vitale, Giulio Mengozzi, Gabriella Gruden, Graziella Bruno

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes

Basil S. Karam, Alejandro Chavez-Moreno, Wonjoon Koh, Joseph G. Akar, Fadi G. Akar

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

High-density lipoproteins attenuate high glucose-impaired endothelial cell signaling and functions: potential implications for improved vascular repair in diabetes

Xing Chen, My-Ngan Duong, Peter J. Psaltis, Christina A. Bursill, Stephen J. Nicholls

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis

Hideki Kushima, Yusaku Mori, Masakazu Koshibu, Munenori Hiromura, Kyoko Kohashi, Michishige Terasaki, Tomoyasu Fukui, Tsutomu Hirano

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study

Shigemasa Tani, Tsukasa Yagi, Wataru Atsumi, Kenji Kawauchi, Rei Matsuo, Atsushi Hirayama

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia

Jean-Charles Fruchart

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)

Naoyuki Kitao, Hideaki Miyoshi, Tomoo Furumoto, Kota Ono, Hiroshi Nomoto, Aika Miya, Chiho Yamamoto, Atsushi Inoue, Kenichi Tsuchida, Naoki Manda, Yoshio Kurihara, Shin Aoki, Akinobu Nakamura, Tatsuya Atsumi, SAIS Study Group

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002–2014)

José M. de Miguel-Yanes, Rodrigo Jiménez-García, Valentín Hernández-Barrera, Manuel Méndez-Bailón, Javier de Miguel-Díez, Ana Lopez-de-Andrés

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients

Ji Eun Jun, Seung-Eun Lee, You-Bin Lee, Ji Yeon Ahn, Gyuri Kim, Sang-Man Jin, Kyu Yeon Hur, Moon-Kyu Lee, Jae Hyeon Kim

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Updates on cardiovascular outcome trials in diabetes

Oliver Schnell, Lars Rydén, Eberhard Standl, Antonio Ceriello, on behalf of the D&CVD EASD Study Group

01.12.2017 | Commentary | Ausgabe 1/2017 Open Access

Increased amputation risk with canagliflozin treatment: behind the large cardiovascular benefit?

Atsushi Tanaka, Koichi Node

01.12.2017 | Study Protocol | Ausgabe 1/2017 Open Access

Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial

Andrea Natali, Lorenzo Nesti, Iacopo Fabiani, Enrico Calogero, Vitantonio Di Bello

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Impact of renal function on the underlying pathophysiology of coronary plaque composition in patients with type 2 diabetes mellitus

Kentaro Kakuta, Kaoru Dohi, Miho Miyoshi, Takashi Yamanaka, Masaki Kawamura, Jun Masuda, Tairo Kurita, Toru Ogura, Norikazu Yamada, Yasuhiro Sumida, Masaaki Ito

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation

Sanam Ebtehaj, Eke G. Gruppen, Mojtaba Parvizi, Uwe J. F. Tietge, Robin P. F. Dullaart

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Human epicardial adipose tissue-derived and circulating secreted frizzled-related protein 4 (SFRP4) levels are increased in patients with coronary artery disease

Qingwei Ji, Jianwei Zhang, Yu Du, Enjun Zhu, Zhijian Wang, Bin Que, Huangtai Miao, Shutian Shi, Xiuchuan Qin, Yingxin Zhao, Yujie Zhou, Fangjun Huang, Shaoping Nie

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials

Marit de Jong, H. Bart van der Worp, Yolanda van der Graaf, Frank L. J. Visseren, Jan Westerink

01.12.2017 | Correction | Ausgabe 1/2017 Open Access

Correction to: Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group

Oliver Schnell, Eberhard Standl, Doina Catrinoiu, Stefano Genovese, Nebojsa Lalic, Jan Skra, Paul Valensi, Dario Rahelic, Antonio Ceriello

01.12.2017 | Correction | Ausgabe 1/2017 Open Access

Correction to: Disruption of endothelial adherens junctions by high glucose is mediated by protein kinase C-β–dependent vascular endothelial cadherin tyrosine phosphorylation

Mehran Haidari, Wei Zhang, James T. Willerson, Richard A. F. Dixon

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)

Guntram Schernthaner, Roger Lehmann, Martin Prázný, Leszek Czupryniak, Kristine Ducena, Peter Fasching, Andrej Janež, Avraham Karasik, Peter Kempler, Emil Martinka, Marina V. Shestakova, Lea Smirčić Duvnjak, Tsvetalina Tankova

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study

Anna Solini, Livia Giannini, Marta Seghieri, Edoardo Vitolo, Stefano Taddei, Lorenzo Ghiadoni, Rosa Maria Bruno

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies

Stijn A. Peeters, Lian Engelen, Jacqueline Buijs, Nish Chaturvedi, John H. Fuller, Anders Jorsal, Hans-Henrik Parving, Lise Tarnow, Simone Theilade, Peter Rossing, Casper G. Schalkwijk, Coen D. A. Stehouwer

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Pioglitazone stabilizes atherosclerotic plaque by regulating the Th17/Treg balance in AMPK-dependent mechanisms

Yuling Tian, Tao Chen, Yan Wu, Lin Yang, Lijun Wang, Xiaojuan Fan, Wei Zhang, Jiahao Feng, Hang Yu, Yanjie Yang, Juan Zhou, Zuyi Yuan, Yue Wu

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains

Etheresia Pretorius, Martin J. Page, Lize Engelbrecht, Graham C. Ellis, Douglas B. Kell

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Tissue-engineered smooth muscle cell and endothelial progenitor cell bi-level cell sheets prevent progression of cardiac dysfunction, microvascular dysfunction, and interstitial fibrosis in a rodent model of type 1 diabetes-induced cardiomyopathy

Masashi Kawamura, Michael J. Paulsen, Andrew B. Goldstone, Yasuhiro Shudo, Hanjay Wang, Amanda N. Steele, Lyndsay M. Stapleton, Bryan B. Edwards, Anahita Eskandari, Vi N. Truong, Kevin J. Jaatinen, Arnar B. Ingason, Shigeru Miyagawa, Yoshiki Sawa, Y. Joseph Woo

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis

Robyn Bruen, Sean Curley, Sarina Kajani, Daniel Crean, Marcella E. O’Reilly, Margaret B. Lucitt, Catherine G. Godson, Fiona C. McGillicuddy, Orina Belton

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Transcatheter aortic valve implantation and surgical aortic valve replacement among hospitalized patients with and without type 2 diabetes mellitus in Spain (2014–2015)

Manuel Mendez-Bailon, Noel Lorenzo-Villalba, Nuria Muñoz-Rivas, Jose Maria de Miguel-Yanes, Javier De Miguel-Diez, Josep Comín-Colet, Valentin Hernandez-Barrera, Rodrigo Jimenez-Garcia, Ana Lopez-de-Andres

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Impact of overweight on left ventricular function in type 2 diabetes mellitus

Makiko Suto, Hidekazu Tanaka, Yasuhide Mochizuki, Jun Mukai, Hiroki Takada, Fumitaka Soga, Kumiko Dokuni, Yutaka Hatani, Keiko Hatazawa, Hiroki Matsuzoe, Hiroyuki Sano, Hiroyuki Shimoura, Junichi Ooka, Kensuke Matsumoto, Yushi Hirota, Wataru Ogawa, Ken-ichi Hirata

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

RETRACTED ARTICLE: Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report

Kyoung Min Kim, Kyong Yeun Jung, Han Mi Yun, Seo Young Lee, Tae Jung Oh, Hak Chul Jang, Soo Lim

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Plasma irisin is elevated in type 2 diabetes and is associated with increased E-selectin levels

Karan S. Rana, Chathyan Pararasa, Islam Afzal, David A. Nagel, Eric J. Hill, Clifford J. Bailey, Helen R. Griffiths, Ioannis Kyrou, Harpal S. Randeva, Srikanth Bellary, James E. Brown

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Effects of hypoglycemia on myocardial susceptibility to ischemia–reperfusion injury and preconditioning in hearts from rats with and without type 2 diabetes

Kim B. Pælestik, Nichlas R. Jespersen, Rebekka V. Jensen, Jacob Johnsen, Hans Erik Bøtker, Steen B. Kristiansen

01.12.2017 | Correction | Ausgabe 1/2017 Open Access

Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin

Toshiyuki Hayashi, Tomoyasu Fukui, Noriko Nakanishi, Saki Yamamoto, Masako Tomoyasu, Anna Osamura, Makoto Ohara, Takeshi Yamamoto, Yasuki Ito, Tsutomu Hirano

01.12.2017 | Correction | Ausgabe 1/2017 Open Access

Correction to: Updates on cardiovascular outcome trials in diabetes

Oliver Schnell, Lars Rydén, Eberhard Standl, Antonio Ceriello, on behalf of the D&CVD EASD Study Group

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Low 1,5-anhydroglucitol levels are associated with long-term cardiac mortality in acute coronary syndrome patients with hemoglobin A1c levels less than 7.0%

Shohei Ouchi, Kazunori Shimada, Tetsuro Miyazaki, Shuhei Takahashi, Yurina Sugita, Megumi Shimizu, Azusa Murata, Tomoyasu Kadoguchi, Takao Kato, Tatsuro Aikawa, Shoko Suda, Eiryu Sai, Masaru Hiki, Hiroshi Iwata, Takatoshi Kasai, Katsumi Miyauchi, Hiroyuki Daida

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Type 2 diabetes mellitus is associated with a lower fibrous cap thickness but has no impact on calcification morphology: an intracoronary optical coherence tomography study

Andrea Milzi, Mathias Burgmaier, Kathrin Burgmaier, Martin Hellmich, Nikolaus Marx, Sebastian Reith

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Adiponectin, biomarkers of inflammation and changes in cardiac autonomic function: Whitehall II study

Christian Stevns Hansen, Dorte Vistisen, Marit Eika Jørgensen, Daniel R. Witte, Eric J. Brunner, Adam G. Tabák, Mika Kivimäki, Michael Roden, Marek Malik, Christian Herder

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

DPP-4 inhibition with linagliptin ameliorates the progression of premature aging in klotho−/− mice

Yu Hasegawa, Kenyu Hayashi, Yushin Takemoto, Cao Cheng, Koki Takane, Bowen Lin, Yoshihiro Komohara, Shokei Kim-Mitsuyama

01.12.2017 | Review | Ausgabe 1/2017 Open Access

Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection

Jake Russell, Eugene F. Du Toit, Jason N. Peart, Hemal H. Patel, John P. Headrick

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Plaque volume and plaque risk profile in diabetic vs. non-diabetic patients undergoing lipid-lowering therapy: a study based on 3D intravascular ultrasound and virtual histology

Tomas Kovarnik, Zhi Chen, Gary S. Mintz, Andreas Wahle, Kristyna Bayerova, Ales Kral, Martin Chval, Karel Kopriva, John Lopez, Milan Sonka, Ales Linhart

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Relative hyperglycemia is associated with complications following an acute myocardial infarction: a post-hoc analysis of HI-5 data

Tien F. Lee, Morton G. Burt, Leonie K. Heilbronn, Arduino A. Mangoni, Vincent W. Wong, Mark McLean, N. Wah Cheung

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II)

Sergey Boytsov, Natalia Logunova, Yunona Khomitskaya, on behalf of the CEPHEUS II investigators

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan

Chia-Yu Chang, Yung-Hsin Yeh, Yi-Hsin Chan, Jia-Rou Liu, Shang-Hung Chang, Hsin-Fu Lee, Lung-Sheng Wu, Kun-Chi Yen, Chi-Tai Kuo, Lai-Chu See

01.12.2017 | Original investigation | Ausgabe 1/2017 Open Access

Impaired ventricular filling limits cardiac reserve during submaximal exercise in people with type 2 diabetes

Genevieve A. Wilson, Gerard T. Wilkins, Jim D. Cotter, Regis R. Lamberts, Sudish Lal, James C. Baldi

Aktuelle Ausgaben


 

Neu im Fachgebiet Innere Medizin

Meistgelesene Bücher aus der Inneren Medizin

2017 | Buch

Rheumatologie aus der Praxis

Entzündliche Gelenkerkrankungen – mit Fallbeispielen

Dieses Fachbuch macht mit den wichtigsten chronisch entzündlichen Gelenk- und Wirbelsäulenerkrankungen vertraut. Anhand von über 40 instruktiven Fallbeispielen werden anschaulich diagnostisches Vorgehen, therapeutisches Ansprechen und der Verlauf …

Herausgeber:
Rudolf Puchner

2016 | Buch

Ambulant erworbene Pneumonie

Was, wann, warum – Dieses Buch bietet differenzierte Diagnostik und Therapie der ambulant erworbenen Pneumonie zur sofortigen sicheren Anwendung. Entsprechend der neuesten Studien und Leitlinien aller wichtigen Fachgesellschaften.

Herausgeber:
Santiago Ewig

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin 

Bildnachweise